1-3 of 3
Katharina Bayer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk Stratification In Chronic Lymphocytic Leukemia Patients With IGHV3-21 Gene Usage According To Presence Of Stereotypy and Mutations In SF3B1

Sabine Jeromin, PhD, Frank Dicker, PhD, Katharina Bayer, Sandra Weissmann, PhD, Christiane Eder, PhD, Manja Meggendorfer, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Torsten Haferlach, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD
Journal: Blood
Blood (2013) 122 (21): 4114.
https://doi.org/10.1182/blood.V122.21.4114.4114
Published: 2013
Journal Articles

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Sabine Jeromin, PhD, Ulrike Bacher, MD, Katharina Bayer, Frank Dicker, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD
Journal: Blood
Blood (2012) 120 (21): 406.
https://doi.org/10.1182/blood.V120.21.406.406
Published: 2012
Journal Articles

SF3B1 Mutations Have Adverse Impact On Time to Treatment Especially in Patients with 13q Deletions: A Study On 1,124 Chronic Lymphocytic Leukemia (CLL) Patients

Sabine Jeromin, PhD, Claudia Haferlach, MD, Katharina Bayer, Frank Dicker, PhD, Sandra Weissmann, PhD, Vera Grossmann, MSc, Tamara Alpermann, Alexander Kohlmann, PhD, Torsten Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD
Journal: Blood
Blood (2012) 120 (21): 709.
https://doi.org/10.1182/blood.V120.21.709.709
Published: 2012